- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有215家主力机构披露2026-06-30报告期持股数据，持仓量总计10.93亿股，占流通A股55.30%
- 波段诊断：
-
技术面诊股
诊断结果：6.8技术面打败了75%的股票
技术面评分前10的股票
近期的平均成本为12.47元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为12.47元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.47","date":1790669608,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑输行业平均水平。
[{"date":"2026.09.30","stock":"3.88","trade":"4.63","ind":"0.31"},{"date":"2026.09.29","stock":"-0.82","trade":"-0.24","ind":"0.18"},{"date":"2026.09.28","stock":"0.99","trade":"-0.08","ind":"-1.67"},{"date":"2026.09.24","stock":"-1.71","trade":"-2.83","ind":"-1.22"},{"date":"2026.09.23","stock":"-0.40","trade":"1.31","ind":"-0.39"},{"date":"2026.09.22","stock":"-0.16","trade":"1.92","ind":"0.06"},{"date":"2026.09.21","stock":"2.55","trade":"4.64","ind":"0.97"},{"date":"2026.09.18","stock":"0.58","trade":"2.61","ind":"0.94"},{"date":"2026.09.17","stock":"0.58","trade":"1.50","ind":"-0.41"},{"date":"2026.09.16","stock":"-1.23","trade":"0.82","ind":"0.71"},{"date":"2026.09.15","stock":"-1.14","trade":"-1.62","ind":"-0.54"},{"date":"2026.09.14","stock":"1.90","trade":"2.96","ind":"-0.07"},{"date":"2026.09.11","stock":"-2.74","trade":"-2.86","ind":"-1.18"},{"date":"2026.09.10","stock":"-1.04","trade":"-2.43","ind":"-0.43"},{"date":"2026.09.09","stock":"-1.34","trade":"-1.46","ind":"0.28"},{"date":"2026.09.08","stock":"3.92","trade":"1.93","ind":"0.20"},{"date":"2026.09.07","stock":"-0.24","trade":"0.09","ind":"0.07"},{"date":"2026.09.04","stock":"0.74","trade":"-0.93","ind":"-0.30"},{"date":"2026.09.03","stock":"0.25","trade":"0.47","ind":"0.02"},{"date":"2026.09.02","stock":"-1.62","trade":"-1.26","ind":"-0.97"},{"date":"2026.09.01","stock":"0.98","trade":"0.61","ind":"-0.16"}]
天坛生物,上证指数,生物制品指数
压力支撑
该股压力位为12.30元，支撑位为12.00元。
[{"text":"\u538b\u529b\u4f4d","value":"12.30","date":1790697600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.00","date":1790697600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.4资金面打败了72%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体无进出。
更新时间：10月02日 20:31
| 机构今日流向(万元) | 2709.56 | 机构5日流向(万元) | -11.22 |
| 机构10日流向(万元) | 2151.24 | 机构20日流向(万元) | -7198.46 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少6892.67万股，其中基金净减仓34家，主力净减仓85家，请投资者中长期谨慎为宜。
截止2026-06-30，共215家主力机构（基金212家，一般法人3家），持仓量总计109341.36万股，占流通A股55.30%
其中，基金持仓与2025-12-31相比：
增仓：44家 ，增持 655.25万股
减仓：78家 ，减持 706.37万股
新出现在主力名单中：69家 ，持有717.08万股
从主力名单中消失：154家 ，原持有8185.51万股
其中，基金持仓与2025-12-31相比：
增仓：44家 ，增持 655.25万股
减仓：78家 ，减持 706.37万股
新出现在主力名单中：69家 ，持有717.08万股
从主力名单中消失：154家 ，原持有8185.51万股
消息面诊股
诊断结果：5.8消息面打败了50%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 天坛生物：9月29日获融资买入746.61万元
2026-09-30 - 天坛生物：9月28日获融资买入580.09万元
2026-09-29 - 国药天坛蓉生注射用重组人凝血因子Ⅷ入选四川省生物制
2026-09-28 - 2026年血液制品行业现状/格局/痛点+发展趋势+
2026-09-28 - 天坛生物：9月24日获融资买入764.03万元
2026-09-25 - XD天坛生：9月23日获融资买入456.91万元
2026-09-24 - 天坛生物：第十届董事会第四次会议决议公告
2026-09-23 - 聚力规范诊疗，护航患者全程！血友病规范化诊疗研讨会
2026-09-23 - 天坛生物：9月22日获融资买入1041.95万元
2026-09-23 - 天坛生物：9月21日获融资买入1467.77万元
2026-09-22
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-24 |
| 一般消息 | 募资投向 | 2026-09-18 | |
| 利好 | 分红转增 | 10派1.0元(含税) | 2026-08-29 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-06-05 |
| 利好 | 分红转增 | 10派0.50元(含税) | 2026-03-28 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-03-07 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-17 |
| 一般消息 | 高管变动 | 工作调整 | 2026-01-16 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-01 |
| 一般消息 | 高管变动 | 工作调整 | 2025-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：8.4行业面打败了99%的股票
生物制品行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2026.09.30","price":"0.31","value":"-0.08"},{"date":"2026.09.29","price":"0.18","value":"-2.83"},{"date":"2026.09.28","price":"-1.67","value":"1.31"},{"date":"2026.09.24","price":"-1.22","value":"1.92"},{"date":"2026.09.23","price":"-0.39","value":"4.64"},{"date":"2026.09.22","price":"0.06","value":"2.61"},{"date":"2026.09.21","price":"0.97","value":"1.50"},{"date":"2026.09.18","price":"0.94","value":"0.82"},{"date":"2026.09.17","price":"-0.41","value":"-1.62"},{"date":"2026.09.16","price":"0.71","value":"2.96"},{"date":"2026.09.15","price":"-0.54","value":"-2.86"},{"date":"2026.09.14","price":"-0.07","value":"-2.43"},{"date":"2026.09.11","price":"-1.18","value":"-1.46"},{"date":"2026.09.10","price":"-0.43","value":"1.93"},{"date":"2026.09.09","price":"0.28","value":"0.09"},{"date":"2026.09.08","price":"0.20","value":"-0.93"},{"date":"2026.09.07","price":"0.07","value":"0.47"},{"date":"2026.09.04","price":"-0.30","value":"-1.26"},{"date":"2026.09.03","price":"0.02","value":"0.61"},{"date":"2026.09.02","price":"-0.97","value":"-2.01"},{"date":"2026.09.01","price":"-0.16","value":"-2.41"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 近岸蛋白 | 121.26% | 28.83% | 6.5分 |
| 2 | 百普赛斯 | 77.25% | 18.75% | 7.0分 |
| 3 | 义翘神州 | 66.34% | 16.72% | 6.9分 |
| 4 | 康希诺 | 35.41% | 28.72% | 5.6分 |
| 5 | 诺唯赞 | 32.81% | 2.99% | 6.3分 |
| 6 | 泰诺麦博 | 31.01% | 20.09% | 5.8分 |
| 8 | 百奥泰 | 18.08% | -0.33% | 6.0分 |
| 10 | 金迪克 | 14.84% | -1.42% | 5.2分 |
| 12 | 科兴制药 | 14.64% | -3.69% | 6.1分 |
| 14 | - | 12.21% | 13.89% | 分 |
| 16 | 智翔金泰 | 10.00% | 0.44% | 5.6分 |
| 18 | 百克生物 | 8.66% | -1.59% | 5.8分 |
| 20 | 康华生物 | 6.86% | 3.49% | 5.8分 |
| 22 | 康弘药业 | 6.45% | 7.34% | 6.1分 |
| 24 | 神州细胞 | 5.80% | 0.65% | 6.2分 |
| 26 | 东宝生物 | 5.20% | 3.21% | 5.9分 |
| 28 | 沃森生物 | 4.48% | 1.50% | 6.0分 |
| 30 | 天坛生物 | 2.69% | 1.86% | 6.3分 |
| 32 | 华兰生物 | 1.91% | 0.53% | 6.0分 |
| 34 | 双成药业 | 0.77% | -2.02% | 6.4分 |
| 36 | 安科生物 | 0.70% | 1.06% | 6.7分 |
| 38 | 博雅生物 | 0.34% | 0.54% | 5.9分 |
| 40 | 智飞生物 | -0.99% | 4.72% | 6.1分 |
| 42 | 三生国健 | -1.19% | -0.53% | 6.5分 |
| 44 | *ST未名 | -2.30% | -5.38% | 5.3分 |
| 46 | 西藏药业 | -2.99% | -0.19% | 6.8分 |
| 48 | 通化东宝 | -4.26% | -0.13% | 6.3分 |
| 50 | - | -4.61% | 0.96% | 分 |
| 52 | 特宝生物 | -6.85% | 1.44% | 6.3分 |
| 54 | 四环生物 | -9.80% | -5.03% | 5.5分 |
| 56 | 信诺维 | - | -6.58% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 20/73 ， 39/73。
[{"date":"2026-06-30","value":"2.53","vol":"-8.07"},{"date":"2026-03-31","value":"1.07","vol":"-6.34"},{"date":"2025-12-31","value":"9.54","vol":"-12.02"},{"date":"2025-09-30","value":"7.24","vol":"-9.89"},{"date":"2025-06-30","value":"5.57","vol":"-3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.53 | 1.07 | 9.54 | 7.24 | 5.57 |
| 行业(%) | -8.07 | -6.34 | -12.02 | -9.89 | -3.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"35.99","vol":"55.74"},{"date":"2026-03-31","value":"34.59","vol":"60.27"},{"date":"2025-12-31","value":"43.85","vol":"65.27"},{"date":"2025-09-30","value":"43.81","vol":"66.41"},{"date":"2025-06-30","value":"45.40","vol":"66.14"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
35.99 | 34.59 | 43.85 | 43.81 | 45.40 |
| 行业(%) | 55.74 | 60.27 | 65.27 | 66.41 | 66.14 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 43/73 ， 43/73。
[{"date":"2026-06-30","value":"-16.56","vol":"31.09"},{"date":"2026-03-31","value":"-13.36","vol":"291.45"},{"date":"2025-12-31","value":"2.26","vol":"39.10"},{"date":"2025-09-30","value":"9.62","vol":"44.93"},{"date":"2025-06-30","value":"9.47","vol":"6771.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.56 | -13.36 | 2.26 | 9.62 | 9.47 |
| 行业(%) | 31.09 | 291.45 | 39.10 | 44.93 | 6771.91 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-52.75","vol":"18.81"},{"date":"2026-03-31","value":"-48.45","vol":"71.92"},{"date":"2025-12-31","value":"-29.59","vol":"36.03"},{"date":"2025-09-30","value":"-22.16","vol":"44.79"},{"date":"2025-06-30","value":"-12.88","vol":"5.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-52.75 | -48.45 | -29.59 | -22.16 | -12.88 |
| 行业(%) | 18.81 | 71.92 | 36.03 | 44.79 | 5.12 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 19/73 ， 28/73。
[{"date":"2026-06-30","value":"0.15","vol":"0.14"},{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.38","vol":"0.30"},{"date":"2025-09-30","value":"0.28","vol":"0.21"},{"date":"2025-06-30","value":"0.19","vol":"0.13"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.07 | 0.38 | 0.28 | 0.19 |
| 行业(次) | 0.14 | 0.06 | 0.30 | 0.21 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.41","vol":"0.63"},{"date":"2026-03-31","value":"0.18","vol":"0.28"},{"date":"2025-12-31","value":"0.88","vol":"1.26"},{"date":"2025-09-30","value":"0.63","vol":"0.88"},{"date":"2025-06-30","value":"0.44","vol":"0.54"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.41 | 0.18 | 0.88 | 0.63 | 0.44 |
| 行业(次) | 0.63 | 0.28 | 1.26 | 0.88 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 16/73 ， 35/73。
[{"date":"2026-06-30","value":"20.97","vol":"-1291.20"},{"date":"2026-03-31","value":"-1.36","vol":"-144.81"},{"date":"2025-12-31","value":"13.03","vol":"12.60"},{"date":"2025-09-30","value":"23.53","vol":"0.21"},{"date":"2025-06-30","value":"5.56","vol":"-1377.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 20.97 | -1.36 | 13.03 | 23.53 | 5.56 |
| 行业 | -1291.20 | -144.81 | 12.60 | 0.21 | -1377.57 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.41","vol":"1.53"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.32","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.43","vol":"1.53"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.41 | - | 1.32 | - | 1.43 |
| 行业 | 1.53 | 0.00 | 1.73 | 0.00 | 1.53 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 42/73 ， 35/73。
[{"date":"2026-06-30","value":"6.98","vol":"5.55"},{"date":"2026-03-31","value":"8.82","vol":"6.58"},{"date":"2025-12-31","value":"8.00","vol":"5.74"},{"date":"2025-09-30","value":"6.01","vol":"5.95"},{"date":"2025-06-30","value":"6.39","vol":"6.47"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
6.98 | 8.82 | 8.00 | 6.01 | 6.39 |
| 行业 | 5.55 | 6.58 | 5.74 | 5.95 | 6.47 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"3.62","vol":"4.13"},{"date":"2026-03-31","value":"4.40","vol":"5.09"},{"date":"2025-12-31","value":"4.07","vol":"4.39"},{"date":"2025-09-30","value":"3.06","vol":"4.79"},{"date":"2025-06-30","value":"3.33","vol":"5.16"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.62 | 4.40 | 4.07 | 3.06 | 3.33 |
| 行业 | 4.13 | 5.09 | 4.39 | 4.79 | 5.16 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 41/73 ， 41/73。
[{"date":"2026-06-30","value":"8.65","vol":"30.05"},{"date":"2026-03-31","value":"7.07","vol":"29.49"},{"date":"2025-12-31","value":"7.64","vol":"29.33"},{"date":"2025-09-30","value":"9.69","vol":"27.48"},{"date":"2025-06-30","value":"9.27","vol":"27.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
8.65 | 7.07 | 7.64 | 9.69 | 9.27 |
| 行业(%) | 30.05 | 29.49 | 29.33 | 27.48 | 27.37 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.12","vol":"1.38"},{"date":"2026-03-31","value":"0.10","vol":"2.52"},{"date":"2025-12-31","value":"0.11","vol":"1.42"},{"date":"2025-09-30","value":"0.14","vol":"0.57"},{"date":"2025-06-30","value":"0.13","vol":"1.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.12 | 0.10 | 0.11 | 0.14 | 0.13 |
| 行业(%) | 1.38 | 2.52 | 1.42 | 0.57 | 1.24 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2026-09-14 | 买入 | 买入 |
| 开源证券 | 2026-08-31 | 买入 | |
| 中国银河 | 2026-08-30 | 增持 | |
| 兴业证券 | 2026-07-26 | 增持 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.81","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.10","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.91","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"9.91","blueLineValue":"0.50","type":"YC"}]